With the right excipients, formulators can control when, where, and how an API is released. Demand for controlled-release formulations is expanding as patients’ expectations for greater convenience ...

The nutraceutical excipients market is projected to rise from USD 4.98 billion in 2025 to USD 7.12 billion by 2030, expanding ...

During the past few years, we've seen a growing interest in direct oral application products, evidenced by the large amount of products already available on the market. During the past few years, ...

Although inactive ingredients enhance a drug product’s physical properties and have been deemed safe, clinical reports documenting adverse reactions caused by excipients have been increasing. 1 In ...

The purpose of formulation development is to ensure that the drug is safe, effective, stable, and convenient to use. If the dosage form is improperly selected and if the prescription and process ...

Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Excipients - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...

The Pharmaceutical Excipients Market is poised for significant growth between 2025 and 2035, driven by the increasing demand for drug formulations and advancements in the pharmaceutical industry.

Functional classification of excipients for tablets and other pharmaceutical products differs for diverse purposes in pharmaceutical preparation and hence may require different material attributes to ...

When it comes to drugs, most of the attention goes to the active pharmaceutical ingredient. But typically the vast majority of what’s in a tablet, capsule, or liquid isn’t the active ingredient. A ...

This article discusses about the current market status, growth and future of excipients and pharmaceutical intermediates in India. First of all, we should discuss briefly, ‘what are excipients?' In ...

The global pharmaceutical excipients market, valued at USD 8.0 billion in 2021, is anticipated to expand at a compound annual growth rate (CAGR) of 5.80%, reaching approximately USD 11.8 billion by ...